Human Cardiac MR Spectroscopy and Sodium MR Imaging

Hall C
Thursday: 13:30 – 15:30

1645.   Abnormal in vivo Cardiac Energetics in Individuals Harbouring the Mitochondrial DNA A3243G Mutation, R. Lodi, B. Rajagopalan, A.M. Blamire, J.G. Crilley, P. Styles, D.M. Turnbull and P.F. Chinnery, University of Oxford, Oxford, UK; University of Bologna, Bologna, Italy and University of Newcastle-upon-Tyne, Newcastle-upon-Tyne, UK.
1646.   Human Cardiac ³¹P MRS During an Oral Glucose Tolerance Test, W.I. Jung, M. Bunse, A. Riefflin, O. Schmidt, M. Heimesaat, O. Lutz and G. Dietze, Max Grundig Clinic, Bühl, Germany and University of Tübingen, Tübingen, Germany.
1647.   Detection of Alterations in the Myocardial High Energy Phosphate Metabolism in Patients with Insulin Dependent Diabetes Mellitus (IDDM), M. Schocke, B. Metzler, C. Wolf, P. Steinboeck, W. Judmaier, M. Lechleitner, O. Pachinger and P. Lukas, University of Innsbruck, Innsbruck, Austria.
1648.   Patients with Familial and Nonfamilial Hypertrophic Cardiomyopathy Show Different Cardiac Energetics, W.I. Jung, L. Sieverding, J. Breuer, M. Bunse, O. Schmidt, S. Widmaier, O. Lutz and G. Dietze, Max Grundig Clinic, Bühl, Germany and University of Tübingen, Tübingen, Germany.
1649.   Metabolic Changes after Carotid Endarterectomy in Patients with Asymptomatic Internal Carotid Artery Flow Lesion by Localized In Vivo Proton Magnetic Resonance Spectroscopy (¹H-MRS), G.E. Kim, Y.P. Cho, J.H. Lee, S-T. Kim, K.H. Lim and T-H. Lim, Asan Medical Center, University of Ulsan College of Medicine and Asan Institute for Life Sciences, Seoul, Korea.
1650.   Cardiac Phosphorus-31 Spectroscopy of Women with Suspected Microvascular Dysfunction, H-W. Kim, A.P. Bruner, S.D.Buchthal, J.A. den Hollander, D.M. Miller, S.P. McGorray, C.J. Pepine, G.M. Pohost and K.N. Scott, University of Florida and VA Medical Center, Gainesville, FL, USA and University of Alabama, Birmingham, AL, USA.
1651.   Time Resolved Sodium Imaging of the Human Heart at 1.5 T, R. Jereèiæ, M. Bock, H-J. Zabel and L.R. Schad, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.

Return to ISMRM program